Table 2

Characterization of noninduced Caco-2 as well as vinblastine-induced and MDR-1-transfected Caco-2 cells with respect to expression of P-gp

CompoundDonor ConcentrationFluxratesMean Factor of Increase
Noninduced Caco-2Vinblastine-induced Caco-2
a → bb → aSecretorya → bb → aSecretory
μm pmol/cm2/h
Vinblastine0.10.15  ± 0.036.2  ± 0.76.0  ± 0.70.09  ± 0.00510.5  ± 0.310.4  ± 0.031.7
R-Talinolol250201  ± 611219  ± 1111013  ± 172146  ± 671788  ± 1921642  ± 2591.6
S-Talinolol250189  ± 651199  ± 113920  ± 178134  ± 661718  ± 1681584  ± 2341.7
Quinidine0.2520.0  ± 0.447.0  ± 0.827.0  ± 1.29.0  ± 0.474.8  ± 8.065.8  ± 8.42.4
MDR-1 transfected Caco-2
a → bb → aSecretory
R-Talinolol25023.0  ± 8.91282  ± 731259  ± 841.2
S-Talinolol25018.1  ± 8.41253  ± 601234  ± 681.3
Quinidine0.253.5  ± 0.342  ± 2.538.5  ± 2.81.4

Typical results for net secretory flux as determined by transport experiments using monolayers of the respective cell line (mean ± S.D., n = 3 for each compound and direction), as well as the resulting mean increase in secretory flux.